Viekirax

Medicinal product

(Invented) name

Viekirax

Active substance (s)

Ombitasviras/Paritapreviras/Ritonaviras

Strength

12,5 mg/75 mg/50 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J05AP53, Ombitasvir, paritaprevir and ritonavir

Marketing authorisation holder

AbbVie Deutschland GmbH & Co. KG , Vokietija

Date of authorisation

2015-01-15

Date of renewal

Documents

Search in EMA Europe

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Film-coated tablet	1 vnt.
Ombitasviras	12,5 mg
Paritapreviras	75 mg
Ritonaviras	50 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
61157	75471	1075471	lizdinė plokštelė	N56 (4x14) (sudėtinė)		Receptinis	EU/1/14/982/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-09-25	Išregistruotas
2015-01-15	Registruotas